In cancer, there is an abnormality in the signaling of PI3K/Akt/mTOR due to which many types of research have been done to find the inhibitors of PI3K/Akt/mTOR signaling which may act as anticancer agents. The gene discussed is PIK3CA; the disease is cancer.